At the third “International Symposium on Health Technology Assessment (ISHTA 2025)” at Bharat Mandapam, New Delh, organised by the Department of Health Research (DHR), Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO) India Country Office and the Centre for Global Development (CGD), Union Minister of Health and Family Welfare, Jagat Prakash Nadda announced the launch of Patent Mitra initiative.
Under the Guidance of NITI AAYOG, Indian Council of Medical Research (ICMR) in partnership with Department of Pharmaceuticals (DoP) and supported by Department for Promotion of Industry and Internal Trade (DPIIT), aims to build a robust and dynamic ecosystem that promotes innovation within biomedical research by providing comprehensive Patent and Technology Transfer (TT) support to innovators at every stage of the patent lifecycle, with a vision to translate innovative research in the biomedical domain to practical solutions driving meaningful advancements in public health across India.
Medical Innovations Patent Mitra Initiative aims to support strategic and quality patent filings for innovative biomedical research with a vision to advance patent protection and facilitate seamless technology transfer for societal impact.
"This platform is designed to provide crucial support to the scientists, researchers and institutions ensuring that their ground-breaking works are protected through patents and made available to public through seamless technology transfer”, the Minister stated.
Nadda also highlighted that the "Medical Education Patent Mitra" initiative of ICMR aligns with the Med Tech Mitra initiative, a testament of ICMR’s commitment to advancing medical innovation.
On the occasion, the Union Health Minister also released several key resources, including the Open Real-Time PCR Kit for Diagnosis of Pulmonary Tuberculosis (Quantiplus MTB FAST Detection Kit developed by Huwel Lifesciences), the HTA Technologies Compendium, and the HTA Costing Database.
